XanGo® Juice May Help Lower Marker of Inflammation and Improve Weight and Body Fat
Mike Pugh, a scientist at XanGo, explains, "The reason why the scientific community is interested in probing inflammation is that it may be an early indicator of heart attack, stroke and diabetes, potentially even lung disease, skin conditions and arthritis. So, scientists test CRP as a first step in assessing an individual's level of inflammation, and then, in turn, they use that to help picture a patient's potential for these serious diseases." Current understanding of body fat suggests that reducing inflammation may also assist in managing one's weight, which may have wellness benefits of its own.
XanGo's chief marketing officer, Larry Macfarlane, elaborates on why XanGo whole-heartedly supported the research performed by Dr. Jay Udani at Medicus Research in California, "Sometimes, consumers turn to pharmaceutical products as a preventive measure to maintain good health. While consumers should always consult with their healthcare provider before changing their dietary regimen, XanGo realizes that our flagship product, XanGo Juice, might provide a natural alternative for maintaining good health."
In the study, Dr. Udani tested three different dosages (varying between three to nine ounces) of XanGo Juice against a placebo juice. Participants consumed the assigned beverages twice a day, in the morning and evening. All three dosages of XanGo Juice demonstrated an ability to reduce CRP as a marker of inflammation. Dr. Udani comments, "Subjects who consumed the highest dose demonstrated a statistically significant reduction in CRP (1.33 mg/L). The other doses had non-significant reductions in CRP while the placebo group actually increased their CRP level."
Body fat percentage was significantly different between the three-ounce juice group and placebo. This three-ounce group also experienced a significantly lower body mass index (BMI) score compared with placebo at eight weeks. The six-ounce group had significantly lower BMI than placebo at four weeks and at eight weeks.
Dr. Udani reports that no side effects or safety concerns emerged at any dosage tested, and cautions that longer studies with larger numbers of participants are needed to confirm the findings and further probe a possible dose-dependent effect. However, this first human clinical trial points to exciting avenues for XanGo Juice's use in the maintenance of heart health and other conditions that may be connected to inflammation.
Previous research shows the xanthones in XanGo Juice may possess antioxidant and anti-inflammatory properties that may help sustain a healthy cardiovascular system, support cartilage and joint function, support the immune system, promote a healthy seasonal respiratory system, maintain intestinal health and neutralize free radicals.*
XanGo Juice is sold by XanGo's global network of more than 1 million independent distributors. To locate a distributor near you, visit http://www.xango.com.
Related News
-
Xango President Earns Stevie Award
XANGO Global President Leslie A. Gallacher was recently selected as an Executive of the Year award winner in the 2015 Stevie Awards for Women in Business Program.Promoted to company president earlier this year, Gallacher has been involved in nearly every function of XANGO's business since 20... Read More...
XANGO Launches Aeris Anti-Aging System
LAS VEGAS, NV , Sep 11, 2015 -- Global wellness and direct sales leader XANGO today at its global convention at the MGM Grand Resort & Casino launched a complete anti-aging solution: XANGO Aeris. Featuring a three-step system to reverse the signs of aging, Aeris firms skin around the eyes, and reduc... Read More...Xango Names Names Ryan Anderson VP of US and Canada Markets
LEHI, UT--March 10, 2015 - XANGO, a global wellness and direct sales leader, today announced the appointment of Ryan Anderson as its new vice president of the U.S. and Canada markets. Anderson returns to XANGO after serving in executive positions in other network marketing companies the past four ye... Read More...XanGo Lawsuits Settle Out of Court
XanGo and a cofounder have settled lawsuits against each other. Bryan Davis, a cofounder of XanGo, sued the company in Federal court in May, alleging it defrauded him and diluted his ownership interest in the company by falsifying financial information that also led Davis to personally guarantee ... Read More...
